A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis

Clinical trial NCT05247216 · COMPLETED

Trial details

NCT number: NCT05247216
Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2021-03-26
Primary completion: 2023-06-22
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.